Schnipper Jeffrey L, Roumie Christianne L, Cawthon Courtney, Businger Alexandra, Dalal Anuj K, Mugalla Ileko, Eden Svetlana, Jacobson Terry A, Rask Kimberly J, Vaccarino Viola, Gandhi Tejal K, Bates David W, Johnson Daniel C, Labonville Stephanie, Gregory David, Kripalani Sunil
Division of General Medicine and Primary Care, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Circ Cardiovasc Qual Outcomes. 2010 Mar;3(2):212-9. doi: 10.1161/CIRCOUTCOMES.109.921833.
Medication errors and adverse drug events are common after hospital discharge due to changes in medication regimens, suboptimal discharge instructions, and prolonged time to follow-up. Pharmacist-based interventions may be effective in promoting the safe and effective use of medications, especially among high-risk patients such as those with low health literacy.
The Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) study is a randomized controlled trial conducted at 2 academic centers-Vanderbilt University Hospital and Brigham and Women's Hospital. Patients admitted with acute coronary syndrome or acute decompensated heart failure were randomly assigned to usual care or intervention. The intervention consisted of pharmacist-assisted medication reconciliation, inpatient pharmacist counseling, low-literacy adherence aids, and tailored telephone follow-up after discharge. The primary outcome is the occurrence of serious medication errors in the first 30 days after hospital discharge. Secondary outcomes are health care utilization, disease-specific quality of life, and cost-effectiveness. Enrollment was completed September 2009. A total of 862 patients were enrolled, and 430 patients were randomly assigned to receive the intervention. Analyses will determine whether the intervention was effective in reducing serious medication errors, particularly in patients with low health literacy.
The PILL-CVD study was designed to reduce serious medication errors after hospitalization through a pharmacist-based intervention. The intervention, if effective, will inform health care facilities on the use of pharmacist-assisted medication reconciliation, inpatient counseling, low-literacy adherence aids, and patient follow-up after discharge. Clinical Trial Registration- clinicaltrials.gov. Identifier: NCT00632021.
由于药物治疗方案的改变、出院指导欠佳以及随访时间延长,出院后用药错误和药物不良事件很常见。基于药师的干预措施可能有助于促进药物的安全有效使用,尤其是在健康素养较低的高危患者中。
心血管疾病低素养患者的药师干预(PILL-CVD)研究是一项在两个学术中心——范德比尔特大学医院和布莱根妇女医院进行的随机对照试验。因急性冠状动脉综合征或急性失代偿性心力衰竭入院的患者被随机分配接受常规护理或干预。干预措施包括药师协助的用药核对、住院期间药师咨询、低素养依从性辅助工具以及出院后的针对性电话随访。主要结局是出院后前30天内严重用药错误的发生情况。次要结局包括医疗保健利用情况、疾病特异性生活质量和成本效益。2009年9月完成入组。共纳入862例患者,430例患者被随机分配接受干预。分析将确定该干预措施是否能有效减少严重用药错误,尤其是在健康素养较低的患者中。
PILL-CVD研究旨在通过基于药师的干预措施减少住院后的严重用药错误。如果该干预措施有效,将为医疗机构提供有关使用药师协助的用药核对、住院咨询、低素养依从性辅助工具以及出院后患者随访的信息。临床试验注册——clinicaltrials.gov。标识符:NCT00632021。